JJJamal Jones

Jamal Jones

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jamal Jones has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Erin Kobetz

    Jay Weiss Center for Social Medicine and Health Equity, University of Miami Miller School of Medicine

    2 shared publications
  • Sonjia Kenya

    Affiliations Department of General Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, United States of America

    2 shared publications
  • Stephen Symes

    Jay Weiss Center Social Medicine and Health Equity, University of Miami Miller School of Medicine

    2 shared publications
  • Alexis Powell

    University of Miami Miller School of Medicine

    1 shared publication
  • Anne Monroe

    Jay Weiss Center for Social Medicine and Health Equity, University of Miami Miller School of Medicine

    1 shared publication
  • Grace Alvarez

    1 shared publication

Latest Publications

  • Using Community Health Workers to Improve Clinical Outcomes Among People Living with HIV: A Randomized Controlled Trial

    by Sonjia Kenya, Jamal Jones, Kristopher Arheart, Erin Kobetz, Natasha Chida, Shelly Baer, Alexis Powell, Stephen Symes, Tai Hunte, Anne Monroe, et al.

    AIDS-related mortality remains a leading cause of preventable death among African-Americans. We sought to determine if community health workers could improve clinical outcomes among vulnerable African-Americans living with HIV in Miami, Florida. We recruited 91 medically indigent persons with HIV viral loads ≥1,000 and/or a CD4 cell count ≤350. Patients were randomized to a community health worker (CHW) intervention or control group. Viral load and CD4 cell count data were abstracted from electronic medical records. At 12 months, the mean VL in the intervention group was log 0.9 copies/μL lower than the control group. The CD4 counts were not significantly different among the groups. Compared to the control group, patients randomized to CHWs experienced statistically significant improvements in HIV viral load. Larger multi-site studies of longer duration are needed to determine whether CHWs should be incorporated into standard treatment models for vulnerable populations living with HIV. La mortalidad relacionada con el SIDA sigue siendo la principal causa de muerte evitable entre los afro-americanos. Nuestro objetivo era determinar si los promotores de salud podrían mejorar los resultados clínicos entre africano-americanos que viven con el VIH en Miami, Florida. Reclutamos a noventa y un personas médicamente indigentes con cargas virales de VIH >1,000 y/o un recuento de células CD4 <350. Los pacientes fueron asignados al azar a un grupo de intervención con un trabajador de salud comunitaria (TSC)/promotor o al grupo control. Los datos de carga viral y recuento de células CD4 fueron extraídos de registros médicos electrónicos. En doce meses, el promedio del VL en el grupo de intervención fué de 0,9 log copias/μL más bajos que los del grupo control. Los recuentos de células CD4 no fueron significativamente diferentes entre los grupos. En comparación con el grupo control, los pacientes asignados al azar a los promotores/TSC experimentaron mejoras estadísticamente significativas en la carga viral de VIH. Estudios de mayor duración y de sitios múltiples son necesarios para determinar si los promotores/TSC deben ser incorporados en los modelos estándar de tratamiento para las poblaciones vulnerables que viven con el VIH.


  • People Living with AIDS Survey

    by Sonjia Kenya, Natasha Chida, Jamal Jones, Grace Alvarez, Stephen Symes, Erin Kobetz